| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |